Age-dependent multisystem parkinsonian features in a novel neuromelanin-producing transgenic mouse model
Objective: We aim to characterize the consequences of age-dependent intracellular neuromelanin accumulation in catecholaminergic neuronal populations to understand the relationship between this process and the…DAT-SPECT in old onset Parkinson’s disease: should we trust?
Objective: . Background: Scans without evidence of dopaminergic deficit (SWEDD) refers to patients clinically diagnosed with Parkinson’s disease (PD), but show normal findings on dopamine…Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease
Objective: Quantify cortical perfusion at baseline and six months after a single infusion of allogeneic bone marrow-derived mesenchymal stem cells (allo-hMSC) in relation to demographic…Dysphagia risk, respiratory muscle strength and maximal phonation time in elderly with Parkinson Disease in the initial stages
Objective: To analyze the risk of dysphagia, respiratory muscle strength (RMS) and maximal phonation time (MPT) in elderly with Parkinson's disease (PD) in the initial stages…Ventilatory function and respiratory muscle strength in Parkinson’s disease at the early stage: observational study.
Objective: To analyze lung function and respiratory muscle strength (RMS) of elderly with PD in early stages (Hoehn & Yahr scale 0-3). Background: Parkinson's disease…Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease
Objective: To define a subset of Parkinson’s disease (PD) symptoms that are present in both individuals with early PD and prodromal PD, compared with age-matched…Falls in people with typical Parkinson’s disease and the secret of unexpected functional mobility. A protocol for a mixed-method study design.
Objective: Understand why some people with typical Parkinson's disease (PwP) show unexpected functional mobility e.g. functional mobility despite the presence of risk factors. Consequently, the…Subclinical inflammation and Parkinson’s disease
Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…Late-onset chorea in the setting of cerebrovascular disease
Objective: Illustrate two cases of late-onset chorea attributable to cerebrovascular disease Background: “Senile chorea” has been used to describe late-onset (age 50+), sporadic, hyperkinetic movements.…Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease
Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 24
- Next Page »